BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23242736)

  • 1. Real-time multi-modality imaging of glioblastoma tumor resection and recurrence.
    Hingtgen S; Figueiredo JL; Farrar C; Duebgen M; Martinez-Quintanilla J; Bhere D; Shah K
    J Neurooncol; 2013 Jan; 111(2):153-61. PubMed ID: 23242736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
    Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
    BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of an imageable surgical resection animal model of Glioblastoma (GBM).
    Sweeney KJ; Jarzabek MA; Dicker P; O'Brien DF; Callanan JJ; Byrne AT; Prehn JH
    J Neurosci Methods; 2014 Aug; 233():99-104. PubMed ID: 24952322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.
    Sheets KT; Ewend MG; Mohiti-Asli M; Tuin SA; Loboa EG; Aboody KS; Hingtgen SD
    Mol Ther; 2020 Apr; 28(4):1056-1067. PubMed ID: 32109370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.
    Höhne J; Schebesch KM; de Laurentis C; Akçakaya MO; Pedersen CB; Brawanski A; Poulsen FR; Kiris T; Cavallo C; Broggi M; Ferroli P; Acerbi F
    World Neurosurg; 2019 May; 125():e158-e164. PubMed ID: 30682505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
    Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
    Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
    Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
    Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
    Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
    Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioluminescence imaging and two-photon microscopy guided laser ablation of GBM decreases tumor burden.
    Fan Y; Sun Y; Chang W; Zhang X; Tang J; Zhang L; Liao H
    Theranostics; 2018; 8(15):4072-4085. PubMed ID: 30128037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid tumor recurrence in a novel murine GBM surgical model is associated with Akt/PD-L1/vimentin signaling.
    Liu F; Xu XH; Li CY; Zhang TT; Yin SL; Liu GQ; Hu F; Yu SB; Chen XQ
    Biochem Biophys Res Commun; 2021 Sep; 569():1-9. PubMed ID: 34216991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.
    Bettag C; Schregel K; Langer P; Thomas C; Behme D; Stadelmann C; Rohde V; Mielke D
    Neurosurg Focus; 2021 Jan; 50(1):E3. PubMed ID: 33386004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of primary and recurrent human glioblastoma multiforme using the small animal imaging and molecular expressive profiles.
    Lin LT; Chiou SH; Lee TW; Liu RS; Hwang JJ; Chang CH; Ma HI; Lee YJ
    Mol Imaging Biol; 2013 Jun; 15(3):262-72. PubMed ID: 22948536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.
    Yano S; Miwa S; Kishimoto H; Toneri M; Hiroshima Y; Yamamoto M; Bouvet M; Urata Y; Tazawa H; Kagawa S; Fujiwara T; Hoffman RM
    Mol Ther; 2015 Jul; 23(7):1182-1188. PubMed ID: 25896244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme.
    Gruslova A; Cavazos DA; Miller JR; Breitbart E; Cohen YC; Bangio L; Yakov N; Soundararajan A; Floyd JR; Brenner AJ
    J Neurooncol; 2015 Sep; 124(3):365-72. PubMed ID: 26108658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo delineation of glioblastoma by targeting tumor-associated macrophages with near-infrared fluorescent silica coated iron oxide nanoparticles in orthotopic xenografts for surgical guidance.
    Lee C; Kim GR; Yoon J; Kim SE; Yoo JS; Piao Y
    Sci Rep; 2018 Jul; 8(1):11122. PubMed ID: 30042406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel model of orthotopic U-87 MG glioblastoma resection in athymic nude mice.
    Bianco J; Bastiancich C; Joudiou N; Gallez B; des Rieux A; Danhier F
    J Neurosci Methods; 2017 Jun; 284():96-102. PubMed ID: 28472680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas.
    Kauer TM; Figueiredo JL; Hingtgen S; Shah K
    Nat Neurosci; 2011 Dec; 15(2):197-204. PubMed ID: 22197831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
    Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
    J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
    Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
    Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
    Smith SJ; Diksin M; Chhaya S; Sairam S; Estevez-Cebrero MA; Rahman R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.